Biocodex

Novapharme

Laboratoires Biocodex

Medical University of South Carolina

Biocedex

UniversitÉ De Poitiers

Bernard M Hublot

Marie-Emmanuelle Le Guern

Philippe Girard

Jean-Marie Gillardin

Laurence Berthon-Cedille

Marc Verleye

Francis Lepage

Rene Levy

Marie-Emmanuelle LeGuern

Rene H Levy

Jacques N Astoin

Gilles Renaud

Joan S Lockard

Richard H Finnell

Jacques A Tor

Henri Blehaut

Philippe G Gayral

David D Mott

Herve Groux

Janet L Fisher

Paul Bernasconi

René Levy

Bertrand Debaene

Myriam Tirault

The present invention relates to a compound of the following formula (I): 

Compounds and methods for treating autism spectrum disorders

Methods for terminating, preventing, and/or treating status epilepticus are generally provided. The method can include administering a prophylactically or therapeutically effective amount of stiripentol or a related compound thereof to an individual in need of treatment of status epilepticus. The individual can be in need of treatment of prolonged status epilepticus, refractory status epilepticus, and/or benzodiazepine-resistant status epilepticus.

Treatment of prolonged status epilepticus

The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.

Medicinal product for treating gastrointestinal ulcers

Compound for use in the treatment of peripheral neuropathies

The present invention relates to a pharmaceutical composition comprising as active substances: and

Synergistic combination of analgesic compounds

The present invention relates to a pharmaceutical composition comprising as active substances: and especially for its use in the prevention or treatment of pain.

The present invention relates to the use of at least one compound of formula (I) below: or at least one of the pharmaceutically acceptable salts thereof, for the preparation of a medicament intended for the prevention or for the treatment of cerebral edemas.

Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas

This invention relates to the use of at least one compound of the following formula (I): or its pharmaceutically acceptable salts, for the preparation of a medicinal compound having neuroprotective activity intended to prevent or treat neurone deteriorations.

Neuroprotective compounds and pharmaceutical compositions comprising them

The present invention relates to a method of treating or preventing weight loss of patients with inflammatory bowel diseases comprising administering to said patients an effective amount of

Method for treating weight loss in patients suffering from inflammatory bowel diseases

The invention relates to a process for the preparation of stiripentol particles having a defined particle size distribution.

Process for the preparation of stiripentol particles having a defined particle size distribution

The present invention relates to the use of at least one compound of formula (I) below: or of its pharmaceutically acceptable salts, in the preparation of a medicament for the prevention or treatment of cerebral oedemas.

Pharmaceutical composition for the prevention or treatment of cerebral oedemas

Process for reducing the extent of Cryptosporidium diarrhoeas, which comprises administering to a patient in need thereof a therapeutically effective amount of yeasts of the Saccharomyces boulardii species. The yeasts are freeze-dried living yeasts. The yeasts are provided in the form of unit doses containing 0.050 to 3.0 g of yeasts.

Process for reducing the extent of cryptosporidium diarrhoeas

The invention relates to a compound useful for treating epilepsy selected from the compounds of the general formula: ##STR1## in which R.sub.1 is C.sub.1 -C.sub.4 alkyl,

N(pyrazol-3-yl) benzamides and pharmaceutical compositions

The object of the invention is heterocyclic compounds of general formula (I) endowed with anticonvulsant activity: ##STR1## in which Y is selected from --O--, --S-- and ##STR2## R.sub.4 being H or optionally substituted alkyl, acyl or benzyl, Z is selected from the groups --CO--N(R.sub.6)--,--NH--CO--CH.dbd.CH-- and --N(R.sub.6)--CO, R.sub.6 being H or alkyl;

3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure

A method for treating epilepsy in humans which comprises administering stiripentol to a patient under antiepileptic treatment with usual drugs in order to alleviate or prevent side effects. The invention also provides an antiepileptic composition comprising stiripentol.

Growing community of inventors

Compiegne, France

Bernard M Hublot